Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 23

Results: 18
    1
    2
    3
    4

    Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.

    Published in:
    European Heart Journal, 2022, v. 43, n. 23, p. 2196, doi. 10.1093/eurheartj/ehac205
    By:
    • Eckhardt, Christina M;
    • Balte, Pallavi P;
    • Barr, Robert Graham;
    • Bertoni, Alain G;
    • Bhatt, Surya P;
    • Cuttica, Michael;
    • Cassano, Patricia A;
    • Chaves, Paolo;
    • Couper, David;
    • Jacobs, David R;
    • Kalhan, Ravi;
    • Kronmal, Richard;
    • Lange, Leslie;
    • Loehr, Laura;
    • London, Stephanie J;
    • O'Connor, George T;
    • Rosamond, Wayne;
    • Sanders, Jason;
    • Schwartz, Joseph E;
    • Shah, Amil
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    European Heart Journal: fulfilling the mission.

    Published in:
    European Heart Journal, 2022, v. 43, n. 23, p. 2181, doi. 10.1093/eurheartj/ehac171
    By:
    • Crea, Filippo;
    • Badimon, Lina;
    • Berry, Colin;
    • Caterina, Raffaele De;
    • Elliott, Perry M;
    • Hatala, Robert;
    • Libby, Peter;
    • Linde, Cecilia;
    • Tybjaerg-Hansen, Anne
    Publication type:
    Article
    11

    Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

    Published in:
    European Heart Journal, 2022, v. 43, n. 23, p. 2185, doi. 10.1093/eurheartj/ehac151
    By:
    • Aktaa, Suleman;
    • Batra, Gorav;
    • Cleland, John G F;
    • Coats, Andrew;
    • Lund, Lars H;
    • McDonagh, Theresa;
    • Rosano, Giuseppe;
    • Seferovic, Petar;
    • Vasko, Peter;
    • Wallentin, Lars;
    • Maggioni, Aldo P;
    • Casadei, Barbara;
    • Gale, Chris P;
    • Cardiology, In Collaboration with the Heart Failure Association of the European Society of
    Publication type:
    Article
    12

    Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.

    Published in:
    European Heart Journal, 2022, v. 43, n. 23, p. 2212, doi. 10.1093/eurheartj/ehac144
    By:
    • Solomon, Scott D;
    • Claggett, Brian L;
    • Miao, Zi Michael;
    • Diaz, Rafael;
    • Felker, G Michael;
    • McMurray, John J V;
    • Metra, Marco;
    • Corbalan, Ramon;
    • Filippatos, Gerasimos;
    • Goudev, Assen R;
    • Mareev, Viatcheslav;
    • Serpytis, Pranas;
    • Suter, Thomas;
    • Yilmaz, Mehmet B;
    • Zannad, Faiez;
    • Kupfer, Stuart;
    • Heitner, Stephen B;
    • Malik, Fady I;
    • Teerlink, John R
    Publication type:
    Article
    13
    14

    Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.

    Published in:
    European Heart Journal, 2022, v. 43, n. 23, p. 2224, doi. 10.1093/eurheartj/ehac103
    By:
    • Tromp, Jasper;
    • Ouwerkerk, Wouter;
    • Teng, Tiew-Hwa K;
    • Cleland, John G F;
    • Bamadhaj, Sahiddah;
    • Angermann, Christiane E;
    • Dahlstrom, Ulf;
    • Tay, Wan Ting;
    • Dickstein, Kenneth;
    • Ertl, Georg;
    • Hassanein, Mahmoud;
    • Perrone, Sergio V;
    • Ghadanfar, Mathieu;
    • Schweizer, Anja;
    • Obergfell, Achim;
    • Collins, Sean P;
    • Filippatos, Gerasimos;
    • Lam, Carolyn S P
    Publication type:
    Article
    15
    16
    17
    18